Trials (Comprehensive Cancer Center Jean Perrin): Revision history

14 December 2025

• curprev 19:1519:15, 14 December 2025‎ Francine talk contribs‎ 55,673 bytes +197‎ No edit summary undo

6 December 2025

• curprev 12:4012:40, 6 December 2025‎ Lucas talk contribs‎ m 55,476 bytes +1,701‎ Update categories. undo

3 December 2025

• curprev 12:0312:03, 3 December 2025‎ Francine talk contribs‎ 53,775 bytes +48‎ No edit summary undo

2 December 2025

• curprev 13:5813:58, 2 December 2025‎ Lucas talk contribs‎ m 53,727 bytes +90‎ Update categories. undo

3 December 2023

• curprev 23:3723:37, 3 December 2023‎ Francine talk contribs‎ 53,637 bytes +53,637‎ Created page with "{{forpatients}} {{forproviders}} {{forresearchers}} Go back to Comprehensive Cancer Center Jean Perrin page '''NCTID''': NCT01491737 '''Title''': A Study of Pertuzumab in Combination With Trastuzumab Plus an Aromatase Inhibitor in Participants With Metastatic Human Epidermal Growth Factor Receptor 2 (HER2)-Positive and Hormone Receptor-Positive Advanced Breast Cancer '''Study Summary''': This randomized, open-label, two-arm, multi-center, Phase II study will eva..."